Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 2 Study of Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant (RiZan Regimen)

NCT07690761 is registered in ClinicalTrials.gov with Bnai Zion Medical Center as lead sponsor.

NCT NCT07690761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07690761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 2 Study of Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant (RiZan Regimen)
Lead sponsor
Bnai Zion Medical Center
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
June 1, 2026
Completion date
December 31, 2033
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hairy cell leukemia, hairy cell leukemia variant